Previous close | 1.4300 |
Open | 1.4200 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 1.4000 - 1.4300 |
52-week range | 1.1400 - 1.8000 |
Volume | |
Avg. volume | 8,182 |
Market cap | 14.632M |
Beta (5Y monthly) | 0.61 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2500 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.30 |
PARIS, April 30, 2024--Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 / Ticker: ALIKO) (Paris:ALIKO), a company specializing in the early and accurate detection of cancer with a unique and fully-automated solution for medical diagnostic labs, announces that the publication of its 2023 annual financial report will be made by May, 27 and not on April, 30.
PARIS, February 29, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces the collaboration of Hospitex International with Allianz Value, a company belonging to Allianz S.p.A. dedicated to both companies’ welfare solutions and home health services and health prevention, for the deployment of the first large-scale screenin
PARIS, February 19, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces that Hospitex International, world leader in thin layer cytology and cancer diagnostics, has won the public tender for the in-service supply of diagnostic systems of the U.O.C. Pathological Anatomy of Ragusa.